Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic Cancer
Clinical trial NCT02459652 · COMPLETED
Trial details
- NCT number
- NCT02459652
- Sponsor
- Japan Adjuvant Study Group of Pancreatic Cancer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-28
- Primary completion
- 2016-05-13
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.